Literature DB >> 31253522

Preventing asthma deaths: above all, do no harm.

Andrew Bush1.   

Abstract

Entities:  

Year:  2019        PMID： 31253522     DOI： 10.1016/S2213-2600(19)30197-3

Source DB:  PubMed          Journal:  Lancet Respir Med        ISSN： 2213-2600            Impact factor:   30.700


× No keyword cloud information.
  6 in total

1.  Oral enoximone allows the reduction and discontinuation of inhaled steroids and beta2 agonists in asthmatic children.

Authors:  Jan Beute; Alex KleinJan
Journal:  Int J Pediatr Adolesc Med       Date:  2021-02-19

2.  A New Pathway to Airway Relaxation: Targeting the "Other" Cyclase in Asthma.

Authors:  Maggie Lam; Jane E Bourke
Journal:  Am J Respir Cell Mol Biol       Date:  2020-01       Impact factor: 6.914

3.  ICS-formoterol reliever versus ICS and short-acting β2-agonist reliever in asthma: a systematic review and meta-analysis.

Authors:  Lee Hatter; Pepa Bruce; Irene Braithwaite; Mark Holliday; James Fingleton; Mark Weatherall; Richard Beasley
Journal:  ERJ Open Res       Date:  2021-01-25

4.  Evaluation of Real-Life Investigational Use of Enoximone in Asthma, the Third Step in Drug Repurposing: A Preliminary Report.

Authors:  Jan Beute; Pieter Boermans; Alex KleinJan
Journal:  Can Respir J       Date:  2021-11-01       Impact factor: 2.409

5.  Challenging the paradigm.

Authors:  Mark L Everard
Journal:  Breathe (Sheff)       Date:  2021-03-08

Review 6.  Precision Medicine and Childhood Asthma: A Guide for the Unwary.

Authors:  Mark L Everard
Journal:  J Pers Med       Date:  2022-01-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.